How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 DEC 27 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM) announced that data from studies involving VELCADE data were featured at the 46th Annual Meeting of the American Society of Hematology in San Diego, California.
Highlights of data from several clinical trials with VELCADE were presented at the meeting include:
Results of several ongoing phase II studies investigating VELCADE alone...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
